TOP STORIES

• BUSINESS Mundipharma Japan Chief Voices Eagerness on Rare Cancer Therapies
  April 25, 2017

• REGULATORY Sakigake Fast-Track Designation Given to Aducanumab, 4 Other Products
  April 24, 2017

• REGULATORY MOF Calls for Scrapping Price Maintenance Premium
  April 21, 2017

• ORGANIZATION Innovation Premium Top Priority for 3 Trade Groups; EFPIA Ideally Wants Its Expansion
  April 20, 2017

• BUSINESS Xarelto Issue Morally Questionable, but Does Not Constitute Misleading Ads Banned under Law: MHLW Officials
  April 20, 2017

• COMMENTARY Will Government Take the Lead in Pricing Debate towards 2017 Fiscal Blueprint?
  April 19, 2017

• BUSINESS Boehringer Japan Logs 14 Consecutive Years of Growth in Ethical Drug Sales
  April 18, 2017

• REGULATORY With Clinical Research Law Enacted, MHLW Eyes New Panel to Discuss Requirements for “Specified Clinical Research”: R&D Division Head
  April 17, 2017

• INTERVIEW Centerpiece of FPMAJ’s Lobbying Push Will Be Price Maintenance Premium: Chairman
  April 14, 2017

• BUSINESS Takeda Chairman Hasegawa to Retire, Become Adviser in June
  April 14, 2017

• BUSINESS Sales Rep and Doctor at Center of Xarelto Survey Scandal Conflict over “Patient Consent”
  April 14, 2017

• ORGANIZATION PhRMA Chair Repeats Call for Keeping Price Maintenance Premium to Secure Market Predictability
  April 13, 2017

• REGULATORY CEFP Social Security Working Group Raises Questions on Price Maintenance Premium, Biosimilar Policy
  April 12, 2017

• COMMENTARY “Cash-and-Carry Dealers” and Their Peculiar Business Practices in the Spotlight in Wake of Counterfeit Harvoni Scandal
  April 12, 2017

• ORGANIZATION JGA Fires Back at Criticism on “Excessive” and “Expensive” Generics, Says No. of Makers Not So Many
  April 11, 2017

• TRENDS Astellas’ LLP Sale to Private Equity Group Signals New Business Model for Older Drugs
  April 10, 2017

• BUSINESS Boehringer Japan to Spur Joint Drug Discovery Research, Eyes 1st Clinical Trial in 2020
  April 7, 2017

• BUSINESS Actelion’s Flolan Generic Outstrips Originator in Pediatric Use with Rare Dosage Nod; Japan Chief Says Company Fulfilling Maker’s Responsibility
  April 6, 2017

• INTERVIEW Scohia Wants to Make Its “Carve Out” a Success Model for Japan Makers: CEO
  April 5, 2017

• REGULATORY “I Don’t Use Biosimilars,” Says Ex-Chief of Japan College of Rheumatology
  April 5, 2017

ページ

• « 先頭
• ‹ Prev
• …
• 153
• 154
• 155
• 156
• 157
• 158
• 159
• 160
• 161
• …
• Next ›
• 最終 »